Document Detail

Cluster protocols in SCIT: enough evidence for practical use?
MedLine Citation:
PMID:  20410818     Owner:  NLM     Status:  MEDLINE    
PURPOSE OF REVIEW: The review provides a comprehensive evaluation of Cluster schedules in subcutaneous-specific immunotherapy (SCIT) in terms of the safety profile and onset of clinical and immunological effects. RECENT FINDINGS: Recent major clinical studies could clearly reveal that Cluster schedules with both (semi-)depot-allergen preparations and chemically modified allergen preparations ('allergoids') are well tolerated therapeutic options in SCIT comparable to the safety profile of conventional build-up schedules. Moreover, preliminary data indicate that these accelerated protocols result in a more rapid achievement of clinical and immunological effects. SUMMARY: Conventional schedules in SCIT have the disadvantage of both a high expenditure of time and the need for a high patient compliance. In accelerated cluster schedules two to three injections are administered sequentially per treatment day (with an interval of 30 min between the injections) in weekly intervals aimed to reach the maintenance dose of SCIT in a short time interval. Recent studies indicate that these accelerated SCIT protocols result in a more rapid achievement of clinical and immunological effects than conventional schedules. Moreover, the safety profile is comparable between conventional and cluster SCIT.
Oliver Pfaar; Sarah Leitzbach; Karl Hörmann; Ludger Klimek
Related Documents :
10623708 - Phase i and pharmacologic study of the specific matrix metalloproteinase inhibitor bay ...
16421428 - Phase i trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib...
12357298 - Phase i and pharmacokinetic study of irinotecan in combination with raltitrexed.
15772958 - Phase i dose-escalation study of tezacitabine in combination with 5-fluorouracil in pat...
2993418 - In vivo administration of purified human interleukin 2. ii. half life, immunologic effe...
24925858 - The accuracy of the out-of-field dose calculations using a model based algorithm in a c...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in allergy and clinical immunology     Volume:  10     ISSN:  1473-6322     ISO Abbreviation:  Curr Opin Allergy Clin Immunol     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-04-30     Completed Date:  2010-09-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100936359     Medline TA:  Curr Opin Allergy Clin Immunol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  188-93     Citation Subset:  IM    
Centre for Rhinology and Allergology (Wiesbaden) of the Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Mannheim, D-65183 Wiesbaden, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Allergens / administration & dosage,  immunology
Clinical Protocols
Clinical Trials as Topic
Desensitization, Immunologic* / adverse effects,  methods
Injections, Subcutaneous
Patient Compliance
Treatment Outcome
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Purified vs. nonpurified venom immunotherapy.
Next Document:  Food allergy and eosinophilic esophagitis.